The US Food and Drug Administration (USFDA) conducted an inspection of the company’s Digwal (Telangana ) based plant from February 9, 2026, to February 13, 2026
Source link
#USFDA #issues #Form #observations #Piramal #Pharmas #Telangana #unit
Trending
- BJP terms GHMC division unscientific, alleges political motive
- This budget laptop deal is absurd: You’re basically buying Windows 11 Pro and Microsoft Office for $279, and getting a 32GB RAM 15.6-inch machine for free
- Amazon, Etsy, other e-commerce stocks pop after Supreme Court rules against Trump’s tariffs
- Six Nations: Louis Rees-Zammit taking inspiration from Manchester United
- How to Outsmart Market Anxiety When Everyone Else Is Panicking
- India a natural collaborator in building inclusive, trusted AI; recognise India’s security interests in Indian Ocean: Lankan President Dissanayake | India News – The Times of India
- Caleb Flynn: Former ‘American Idol’ Contestant Arrested For Wife’s Murder
- Winter Olympics 2026: Four men, one aim – to end 102-year wait for curling gold
USFDA issues Form 483 with 4 observations to Piramal Pharma’s Telangana unit
